Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome (Q47678098)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

neoplastic stem cells

1 reference

based on heuristic

inferred from title

papillary thyroid cancer

1 reference

based on heuristic

inferred from title

anaplastic thyroid carcinoma

1 reference

based on heuristic

inferred from title

author name string

Ji Yun Yun

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Young A Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Ji-Young Choe

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Hyesook Min

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Kyu Sang Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Youngho Jung

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Sohee Oh

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Ji Eun Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

language of work or name

0 references

publication date

28 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

67

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

125-133

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Anaplastic thyroid carcinoma: current diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Results of combined treatment of anaplastic thyroid carcinoma (ATC)

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Targeting cancer stem cell lines as a new treatment of human cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Cancer stem cells and their potential implications for the treatment of solid tumors

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Cancer stem cells and novel targets for antitumor strategies

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Breast cancer stem cells.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Current strategies for identification of glioma stem cells: adequate or unsatisfactory?

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Characterization of Xenopus cytosolic thyroid-hormone-binding protein (xCTBP) with aldehyde dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Transcriptional control of lung morphogenesis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Activation of the hedgehog pathway in a subset of lung cancers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Cancer stem cells: a new framework for the design of tumor therapies.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Brain-tumour drug resistance: the bare essentials

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201711

21 January 2018

Identifiers

10.1136/JCLINPATH-2013-201711

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

release_zqdh4e7l5vdc3knnfqy5wmpkje

1 reference

https://api.fatcat.wiki/v0/release/zqdh4e7l5vdc3knnfqy5wmpkje

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/23986551

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47678098&oldid=2165201988"